Trial Profile
Persistence with denosumab therapy among osteoporotic women in the Canadian patient-support program
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2016
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 27 Feb 2016 New trial record